Article
KIT mutations in ocular melanoma: frequency and anatomic distribution.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Aug 2011
Wallander Michelle L, Layfield Lester J, Emerson Lyska L, Mamalis Nick, Davis Don, Tripp Sheryl R, Holden Joseph A
Abstract excerpt
KIT mutations are known to occur in ~15% of chronic sun damaged cutaneous, mucosal, and acral melanomas. Melanomas with demonstrated activating mutations in KIT or platelet-derived growth factor receptor A (PDGFRA) may benefit from treatment with tyrosine kinase inhibitors. Currently, the limited data regarding KIT mutational status in ocular melanoma suggest that activating mutations are extremely rare. PDGFRA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
